Publics' knowledge of, attitude to and motivation towards health-related genomics: a scoping review.

Autor: Pearce A; Clinical Translation & Engagement, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. a.pearce@garvan.org.au.; School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW, Australia. a.pearce@garvan.org.au., Mitchell LA; Clinical Translation & Engagement, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW, Australia., Best S; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Victorian Comprehensive Cancer Centre Alliance, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Australian Genomics Health Alliance, Melbourne, VIC, Australia., Young MA; Clinical Translation & Engagement, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW, Australia., Terrill B; Clinical Translation & Engagement, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of NSW, Sydney, NSW, Australia.; Australian Genomics Health Alliance, Melbourne, VIC, Australia.
Jazyk: angličtina
Zdroj: European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Jul; Vol. 32 (7), pp. 747-758. Date of Electronic Publication: 2024 Feb 06.
DOI: 10.1038/s41431-024-01547-5
Abstrakt: The use of genomic data in research and genomic information in clinical care is increasing as technologies advance and sequencing costs decrease. Using Rogers' Diffusion of Innovation (DOI) theory as a framework we reviewed recent literature examining publics' current knowledge of, attitude to, and motivation towards health-related genomics in clinical and research settings. The population of interest was described as 'publics' to denote the heterogeneity of 'the public'. Eligible studies were published in English between 2016-2022. We retrieved 1657 records, with 278 full-text reviewed against the eligibility criteria and concept definitions. In total, 99 articles were included in the review and descriptive numerical summaries were collated. Knowledge literature was categorized using deductive thematic analysis. For attitude and motivation, literature was coded using an analytic framework developed by the authors. There was wide variability in concept definition and measurement across studies. Overall, there was general positivity about genomics, with high awareness but little familiarity or factual knowledge. Publics had high expectations of genomics and perceived that it could provide them with information for their future. Only a few key attitudes were found to be important as motivators or barriers for participation in genomics; these were related to personal and clinical utility of the information. Context was often missing from studies, decreasing the utility of findings for implementation or public engagement. Future research would benefit by using theory-driven approaches to assess relevant publics' knowledge and attitudes of specific contexts or applications to support genomic implementation and informed decision-making.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: